School of Medicine
Showing 501-520 of 13,047 Results
-
Anand Athavale, MD
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Anand Athavale is a board-certified, fellowship-trained vascular medicine specialist with Stanford Health Care Vascular and Endovascular Care. He is also a clinical assistant professor in the Department of Surgery, Division of Vascular Surgery at Stanford University School of Medicine.
Dr. Athavale cares for people with conditions of the veins and lymphatic system, including chronic venous disease, blood clots, and poor blood flow in the legs. He is skilled in using less invasive procedures to treat vein problems and helps patients manage their overall vascular health.
His research looks at new and better ways to treat vein disease, test new closure techniques, and use tools such as artificial intelligence to improve care. His research efforts have earned him grants and scholarships from organizations such as the Society for Vascular Medicine and American Venous Forum.
Dr. Athavale has published many studies in peer-reviewed medical journals, including the Journal of Vascular Surgery and Indian Journal of Critical Care Medicine. He has also written chapters for medical textbooks on topics such as lung infections and infections related to HIV. Additionally, he has shared his work at major medical conferences in the United States and abroad, including the annual scientific sessions of the Society for Vascular Medicine.
Dr. Athavale is a member of the Society of Vascular Medicine and the American Venous Forum. -
Alan Atkins
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Al Atkins is a psychiatrist providing talk therapy and medical management in English and Spanish.
Dr. Atkins grew up in California and started his mental health career facilitating therapy at a prison in Buenos Aires. He teamed up with his patients and colleagues to build a climbing wall inside the prison, allowing patients to challenge themselves physically and mentally. After medical school at Brown University, Dr. Atkins completed psychiatry residency and founded a research team dedicated to investigating the healing power of walking in nature. After residency, Dr. Atkins traveled to Colorado to complete a two year fellowship in Child and Adolescent Psychiatry. There, he served as Chief Fellow and pursued specialized therapy training. Dr. Atkins has been awarded the Kimberly Kelsay Curiosity Award for his enthusiasm for learning from his patients and the Catcher in the Rye award for "going the extra mile" for his Spanish-speaking Unaccompanied Refugee Minor (URM) patients. Some career highlights have included teaching meditation neuroscience to doctors in Cambodia and getting to learn from doctors and patients in Kumasi, Ghana.
Contemplative practice, psychotherapy, humor and nature time permeate both Dr. Atkins' clinical and personal interests. His clinical style involves a slow-moving dynamic emphasizing trust, understanding, and diagnostic humility. He takes an integrative and minimalist approach; often prescribing things like morning walks or returning to a favorite hobby before resorting to medications. -
Aparna Atluru, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsPhysician Mental Health, Resident Mental Health
-
Ashish Atreja
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI work at the intersection of health care technology and artificial intelligence. My primary clinical specialty is Gastroenterology and my focus on AI is broad application and validation of clinical AI across diverse use cases.
After completing a master's in public health at the University of Illinois at Chicago, I have completed internal medicine residency, informatics fellowship, and gastroenterology fellowship at the Cleveland Clinic. I have been working at the intersection of technology and healthcare for the last 25 years, was the first gastroenterologist to receive informatics board certification. In leadership roles, I have led Epic implementations as informaticist, served as the Chief Innovation Officer, Medicine at Mount Sinai, New York, and most recently as CIO and inaugural Chief Digital Health Officer at UC Davis Health. For my executive roles, I have been recognized with numerous national honors, including being named one of the Top Digital Health Officers by Becker’s, a Top 40 Healthcare Transformer in 2017, a Top 50 Healthcare Leader by HIMSS in 2021, a Top 30 Health IT Influencer by Health Tech Magazine in 2022, a Top 150 Business Transformer Across global industries by Constellation Research and a top 35 Digital Health officer by Beckers in 2023.
As a digital health entrepreneur, I have successfully licensed technologies, and founded companies originating from academic medical centers. I was the co-founder of Rx.Health, a venture-backed spinout from Mount Sinai Health System that automated digital care delivery for major organizations including UnitedHealthcare and five of the top ten health systems in the U.S., ultimately impacting over 90 million patient lives before its successful acquisition. As a co-founder of GenServe.AI, I am currently working with a team focused on democratizing access to secure Generative AI and autonomous care for all.
I have been NIH-funded since 2014, including for IBD digital monitoring, have published more than 108 peer-reviewed articles and delivered over 250 posters, abstracts, and talks at national meetings. My research focuses on building, implementing, and evaluating digital health and AI-powered solutions aimed at improving patient and population outcomes, for which I am also known as the "App Doctor." -
Laura Attardi
Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics
Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
